OOIR: Observatory of International Research

Papers

(The H4-Index of Circulation-Genomic and Precision Medicine is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association	196
International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework	108
Alcohol Consumption and Cardiovascular Disease	97
Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes	79
Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction	69
Variant Interpretation for Dilated Cardiomyopathy	63
Interactions Between Enhanced Polygenic Risk Scores and Lifestyle for Cardiovascular Disease, Diabetes, and Lipid Levels	60
Polygenic Hyperlipidemias and Coronary Artery Disease Risk	57
Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions: A Scientific Statement From the American Heart Association	57
Implications of Genetic Testing in Dilated Cardiomyopathy	52
Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart As	51
Metabolic Age Based on the BBMRI-NL ¹ H-NMR Metabolomics Repository as Biomarker of Age-related Disease	46
How Communicating Polygenic and Clinical Risk for Atherosclerotic Cardiovascular Disease Impacts Health Behavior: an Observational Follow-up Study	45
Genetic Testing for Heritable Cardiovascular Diseases in Pediatric Patients: A Scientific Statement From the American Heart Association	43
Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy	43
HeterozygousABCG5Gene Deficiency and Risk of Coronary Artery Disease	42
Spontaneous Coronary Artery Dissection	42
Transethnic Meta-Analysis of Genome-Wide Association Studies Identifies Three New Loci and Characterizes Population-Specific Differences for Coronary Artery Disease	42
Whole Blood DNA Methylation Signatures of Diet Are Associated With Cardiovascular Disease Risk Factors and All-Cause Mortality	40
Multiple Somatic Mutations for Clonal Hematopoiesis Are Associated With Increased Mortality in Patients With Chronic Heart Failure	39
SCN5A Mutation Type and a Genetic Risk Score Associate Variably With Brugada Syndrome Phenotype in SCN5A Families	39
Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia	33
Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy	33
Reevaluation of the South Asian MYBPC3 ^Δ25bp Intronic Deletion in Hypertrophic Cardiomyopathy	30
Genetic Testing for Diagnosis of Hypertrophic Cardiomyopathy Mimics	28

De Novo Damaging Variants, Clinical Phenotypes, and Post-Operative Outcomes in Congenital Heart Disease	28
Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis	27
Population Bias in Polygenic Risk Prediction Models for Coronary Artery Disease	27
Clinical Profile of Cardiac Involvement in Danon Disease	27